JP2014519928A - 麻酔回路およびこの麻酔回路を使用するための方法 - Google Patents
麻酔回路およびこの麻酔回路を使用するための方法 Download PDFInfo
- Publication number
- JP2014519928A JP2014519928A JP2014516143A JP2014516143A JP2014519928A JP 2014519928 A JP2014519928 A JP 2014519928A JP 2014516143 A JP2014516143 A JP 2014516143A JP 2014516143 A JP2014516143 A JP 2014516143A JP 2014519928 A JP2014519928 A JP 2014519928A
- Authority
- JP
- Japan
- Prior art keywords
- membrane
- anesthetic
- fluid mixture
- flow path
- exhaled
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010002091 Anaesthesia Diseases 0.000 title claims abstract description 61
- 230000037005 anaesthesia Effects 0.000 title claims abstract description 61
- 238000000034 method Methods 0.000 title claims abstract description 23
- 239000012528 membrane Substances 0.000 claims abstract description 345
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims abstract description 188
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 100
- 239000001301 oxygen Substances 0.000 claims abstract description 100
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 100
- 239000001569 carbon dioxide Substances 0.000 claims abstract description 94
- 229910002092 carbon dioxide Inorganic materials 0.000 claims abstract description 94
- 239000003193 general anesthetic agent Substances 0.000 claims abstract description 29
- 229940035674 anesthetics Drugs 0.000 claims abstract description 25
- 239000000463 material Substances 0.000 claims abstract description 25
- 239000012530 fluid Substances 0.000 claims description 246
- 230000003444 anaesthetic effect Effects 0.000 claims description 187
- 239000000203 mixture Substances 0.000 claims description 166
- 239000012510 hollow fiber Substances 0.000 claims description 52
- 229920000306 polymethylpentene Polymers 0.000 claims description 22
- 239000011116 polymethylpentene Substances 0.000 claims description 22
- 229920000642 polymer Polymers 0.000 claims description 21
- 239000011358 absorbing material Substances 0.000 claims description 20
- DFEYYRMXOJXZRJ-UHFFFAOYSA-N sevoflurane Chemical compound FCOC(C(F)(F)F)C(F)(F)F DFEYYRMXOJXZRJ-UHFFFAOYSA-N 0.000 claims description 19
- 238000004891 communication Methods 0.000 claims description 18
- 229960002078 sevoflurane Drugs 0.000 claims description 18
- 229940024606 amino acid Drugs 0.000 claims description 13
- 150000001413 amino acids Chemical class 0.000 claims description 13
- -1 amino compound Chemical class 0.000 claims description 13
- PIWKPBJCKXDKJR-UHFFFAOYSA-N Isoflurane Chemical compound FC(F)OC(Cl)C(F)(F)F PIWKPBJCKXDKJR-UHFFFAOYSA-N 0.000 claims description 12
- 230000001939 inductive effect Effects 0.000 claims description 12
- 229960002725 isoflurane Drugs 0.000 claims description 12
- 239000002207 metabolite Substances 0.000 claims description 12
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 9
- DPYMFVXJLLWWEU-UHFFFAOYSA-N desflurane Chemical compound FC(F)OC(F)C(F)(F)F DPYMFVXJLLWWEU-UHFFFAOYSA-N 0.000 claims description 8
- 229960003537 desflurane Drugs 0.000 claims description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 7
- 229910052799 carbon Inorganic materials 0.000 claims description 7
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N Alanine Chemical compound CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 claims description 6
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 6
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 claims description 6
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 claims description 6
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 claims description 6
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Chemical compound CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 6
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 claims description 6
- 239000002131 composite material Substances 0.000 claims description 6
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 claims description 6
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims description 6
- 239000003983 inhalation anesthetic agent Substances 0.000 claims description 6
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 claims description 6
- 230000000717 retained effect Effects 0.000 claims description 6
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 6
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 5
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 5
- HUAUNKAZQWMVFY-UHFFFAOYSA-M sodium;oxocalcium;hydroxide Chemical compound [OH-].[Na+].[Ca]=O HUAUNKAZQWMVFY-UHFFFAOYSA-M 0.000 claims description 5
- 235000008733 Citrus aurantifolia Nutrition 0.000 claims description 4
- 235000011941 Tilia x europaea Nutrition 0.000 claims description 4
- 239000004571 lime Substances 0.000 claims description 4
- 229920001296 polysiloxane Polymers 0.000 claims description 4
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 3
- 239000004475 Arginine Substances 0.000 claims description 3
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 claims description 3
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 3
- 239000005977 Ethylene Substances 0.000 claims description 3
- 239000004471 Glycine Substances 0.000 claims description 3
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 claims description 3
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 3
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 3
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 3
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 3
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 3
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 claims description 3
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 claims description 3
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 3
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 3
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 3
- 239000004473 Threonine Substances 0.000 claims description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical group OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 3
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 claims description 3
- 150000001447 alkali salts Chemical class 0.000 claims description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 3
- 229960003121 arginine Drugs 0.000 claims description 3
- 229940000635 beta-alanine Drugs 0.000 claims description 3
- 229960003624 creatine Drugs 0.000 claims description 3
- 239000006046 creatine Substances 0.000 claims description 3
- 229950010030 dl-alanine Drugs 0.000 claims description 3
- 150000002170 ethers Polymers 0.000 claims description 3
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims description 3
- 229960002449 glycine Drugs 0.000 claims description 3
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 3
- 229960002885 histidine Drugs 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 229960000310 isoleucine Drugs 0.000 claims description 3
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 3
- 229960003104 ornithine Drugs 0.000 claims description 3
- JSSXHAMIXJGYCS-UHFFFAOYSA-N piperazin-4-ium-2-carboxylate Chemical compound OC(=O)C1CNCCN1 JSSXHAMIXJGYCS-UHFFFAOYSA-N 0.000 claims description 3
- NIBJBHRBFKKLFG-MUWMCQJSSA-M potassium;(2s,3r)-2,3,4-trihydroxybutanoate Chemical compound [K+].OC[C@@H](O)[C@H](O)C([O-])=O NIBJBHRBFKKLFG-MUWMCQJSSA-M 0.000 claims description 3
- GZWNUORNEQHOAW-UHFFFAOYSA-M potassium;2-aminoacetate Chemical compound [K+].NCC([O-])=O GZWNUORNEQHOAW-UHFFFAOYSA-M 0.000 claims description 3
- 229960002429 proline Drugs 0.000 claims description 3
- 229960001153 serine Drugs 0.000 claims description 3
- 229960003080 taurine Drugs 0.000 claims description 3
- 229960002898 threonine Drugs 0.000 claims description 3
- 239000002861 polymer material Substances 0.000 claims description 2
- 229920005597 polymer membrane Polymers 0.000 claims description 2
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 150000002431 hydrogen Chemical class 0.000 claims 1
- 239000008280 blood Substances 0.000 description 18
- 210000004369 blood Anatomy 0.000 description 18
- 210000004072 lung Anatomy 0.000 description 16
- 239000000126 substance Substances 0.000 description 9
- 230000008569 process Effects 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 239000012466 permeate Substances 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 230000006870 function Effects 0.000 description 5
- 239000007789 gas Substances 0.000 description 5
- 238000009987 spinning Methods 0.000 description 5
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 5
- 238000009792 diffusion process Methods 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 229910052724 xenon Inorganic materials 0.000 description 4
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 3
- 229940126062 Compound A Drugs 0.000 description 3
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 3
- 125000004429 atom Chemical group 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000007675 cardiac surgery Methods 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000011144 upstream manufacturing Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 239000006096 absorbing agent Substances 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 150000008282 halocarbons Chemical class 0.000 description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000004941 mixed matrix membrane Substances 0.000 description 2
- 239000002808 molecular sieve Substances 0.000 description 2
- 229910052756 noble gas Inorganic materials 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 229920003242 poly[1-(trimethylsilyl)-1-propyne] Polymers 0.000 description 2
- 229920000098 polyolefin Polymers 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 2
- 230000009469 supplementation Effects 0.000 description 2
- 208000010444 Acidosis Diseases 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 235000004443 Ricinus communis Nutrition 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 230000007950 acidosis Effects 0.000 description 1
- 208000026545 acidosis disease Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000007177 brain activity Effects 0.000 description 1
- UBAZGMLMVVQSCD-UHFFFAOYSA-N carbon dioxide;molecular oxygen Chemical compound O=O.O=C=O UBAZGMLMVVQSCD-UHFFFAOYSA-N 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 238000002144 chemical decomposition reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 229940052308 general anesthetics halogenated hydrocarbons Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000003434 inspiratory effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 230000003589 nefrotoxic effect Effects 0.000 description 1
- 231100000381 nephrotoxic Toxicity 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 238000004382 potting Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000002407 reforming Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000002145 thermally induced phase separation Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- DCGLONGLPGISNX-UHFFFAOYSA-N trimethyl(prop-1-ynyl)silane Chemical compound CC#C[Si](C)(C)C DCGLONGLPGISNX-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/0087—Environmental safety or protection means, e.g. preventing explosion
- A61M16/009—Removing used or expired gases or anaesthetic vapours
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/0057—Pumps therefor
- A61M16/0084—Pumps therefor self-reinflatable by elasticity, e.g. resuscitation squeeze bags
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/0087—Environmental safety or protection means, e.g. preventing explosion
- A61M16/009—Removing used or expired gases or anaesthetic vapours
- A61M16/0093—Removing used or expired gases or anaesthetic vapours by adsorption, absorption or filtration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/01—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes specially adapted for anaesthetising
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/08—Bellows; Connecting tubes ; Water traps; Patient circuits
- A61M16/0883—Circuit type
- A61M16/0891—Closed circuit, e.g. for anaesthesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/10—Preparation of respiratory gases or vapours
- A61M16/105—Filters
- A61M16/106—Filters in a path
- A61M16/1065—Filters in a path in the expiratory path
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D53/00—Separation of gases or vapours; Recovering vapours of volatile solvents from gases; Chemical or biological purification of waste gases, e.g. engine exhaust gases, smoke, fumes, flue gases, aerosols
- B01D53/22—Separation of gases or vapours; Recovering vapours of volatile solvents from gases; Chemical or biological purification of waste gases, e.g. engine exhaust gases, smoke, fumes, flue gases, aerosols by diffusion
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D63/00—Apparatus in general for separation processes using semi-permeable membranes
- B01D63/02—Hollow fibre modules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/08—Bellows; Connecting tubes ; Water traps; Patient circuits
- A61M16/0816—Joints or connectors
- A61M16/0833—T- or Y-type connectors, e.g. Y-piece
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/10—Preparation of respiratory gases or vapours
- A61M16/104—Preparation of respiratory gases or vapours specially adapted for anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/22—Carbon dioxide-absorbing devices ; Other means for removing carbon dioxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2206/00—Characteristics of a physical parameter; associated device therefor
- A61M2206/10—Flow characteristics
- A61M2206/14—Static flow deviators in tubes disturbing laminar flow in tubes, e.g. archimedes screws
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2311/00—Details relating to membrane separation process operations and control
- B01D2311/13—Use of sweep gas
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
- F04C—ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT PUMPS
- F04C2270/00—Control; Monitoring or safety arrangements
- F04C2270/04—Force
- F04C2270/041—Controlled or regulated
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02C—CAPTURE, STORAGE, SEQUESTRATION OR DISPOSAL OF GREENHOUSE GASES [GHG]
- Y02C20/00—Capture or disposal of greenhouse gases
- Y02C20/40—Capture or disposal of greenhouse gases of CO2
Landscapes
- Health & Medical Sciences (AREA)
- Anesthesiology (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Emergency Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biodiversity & Conservation Biology (AREA)
- Environmental Sciences (AREA)
- Environmental & Geological Engineering (AREA)
- Ecology (AREA)
- General Chemical & Material Sciences (AREA)
- Critical Care (AREA)
- Analytical Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
流路と;
外部麻酔薬を流路内へ導入するために流路と流体連通する麻酔薬入口と;
少なくとも外部麻酔薬を患者へ与えるために流路と流体連通する流出出口と;
吐出流体混合物を患者から受けるための流入入口であって、
吐出流体混合物が、吐出酸素、吐出二酸化炭素、および、吐出分子麻酔薬を含み、流路が、吐出流体混合物を流入入口から受けるために流入入口と流体連通し、
膜が、少なくとも1つの高分子材料を含み、流路に流体連通し、流入入口よりも下流側に配置され、吐出流体混合物が膜と接触した後に吐出分子麻酔薬を流路内に少なくとも部分的に保持するために吐出分子麻酔薬を少なくとも部分的に透過させず、
1よりも大きい吐出酸素対吐出分子麻酔薬選択性を膜が有するように、膜が吐出酸素を透過させ、
1よりも大きい吐出二酸化炭素対吐出分子麻酔薬選択性を膜が有するように、膜が吐出二酸化炭素を透過させ、
吐出流体混合物よりも吐出二酸化炭素の量が少ない改質流体混合物を流路内に残すように、吐出流体混合物が膜と接触し、
流出出口は、膜よりも下流側に位置されるとともに、少なくとも改質流体混合物を患者に与える、流入入口と;
患者へ与えられる改質流体混合物に加えられるべき外部流体を流路内へ導入するための流体入口と;
を備える。
分子麻酔薬を含む外部麻酔薬を、流路を介して患者へ向けて患者内に導入するステップと、
吐出酸素、吐出二酸化炭素、および吐出分子麻酔薬を含む吐出流体混合物を患者から離れるように患者の外へと流路内へ方向付けるステップと、
高分子材料を含むとともに流路と流体連通する膜へ向けて、吐出流体混合物を流路を通じて進めて膜と接触させるステップと、
改質流体混合物を流路内に残すように吐出流体混合物が膜と接触した後に、吐出分子麻酔薬よりも多い吐出二酸化炭素を吐出流体混合物から膜を通じて流路の外へ移送するステップであって、改質流体混合物は吐出流体混合物よりも低い濃度の吐出二酸化炭素を有する、ステップと、
改質流体混合物を流路内に残すように吐出流体混合物が膜と接触した後に、吐出酸素を膜を通じて移送するステップであって、膜が1よりも大きい吐出酸素対吐出分子麻酔薬選択性を有する、ステップと、
少なくとも改質流体混合物を患者に与えるために、改質流体混合物を流路を通じて患者へと進めるステップと、
を含む。
12 流路
14 麻酔薬入口
16 外部麻酔薬
18 麻酔器
20 患者
22 流出出口
24 Y字状ピース
26 吐出流体混合物
28 吐出酸素
30 吐出二酸化炭素
34 吐出分子麻酔薬
36 流入入口
38 膜
40 膜ハウジング
42 改質流体混合物
44 ハウジング入口
46 ハウジング出口
48 流体の流れ方向
50 流体入口
52 外部流体源、外部空気源
56 外部酸素源
58 流れ発生器
59 圧縮性部材、圧縮性チャンバ
60 対向壁
61 プランジャ
62 弁
64 乱流誘発構成要素
65 二次酸素
66 二酸化炭素吸収材料
68 内面
70 流入方向
72 中空繊維
74 単一中実層
76 血液入口
78 血液出口
80 掃引入口
82 掃引出口
83 高密度層
84 掃引流体
85 多孔質支持層
86 高分子
87 中空繊維内部
88 溶媒
89 中空繊維外部
90 ミキサー
92 混合物
94 熱源
96 熱押出機
98 窒素流体源
100 空隙
102 紡ぎチャンバ
106 抽出チャンバ
108 高温アルコール
110 乾燥ステージ
112 スプール
Claims (24)
- 患者を治療するための麻酔回路であって、
流路と;
外部麻酔薬を前記流路内へ導入するために前記流路と流体連通する麻酔薬入口と;
少なくとも前記外部麻酔薬を前記患者へ供給するための前記流路と流体連通する流出出口と;
吐出流体混合物を前記患者から受けるための流入入口であって、
前記吐出流体混合物が、吐出酸素、吐出二酸化炭素、および吐出分子麻酔薬を含み、前記流路が、前記吐出流体混合物を前記流入入口から受けるために前記流入入口と流体連通し、
膜が、少なくとも1つの高分子材料を含み、前記流路に流体連通し、前記流入入口よりも下流側に位置し、前記吐出分子麻酔薬に対して少なくとも部分的に不透過性であって、それにより、前記吐出流体混合物が前記膜と接触した後に前記吐出分子麻酔薬を前記流路内に少なくとも部分的に保持し、
1よりも大きい吐出酸素対吐出分子麻酔薬選択性を前記膜が有するように、前記膜は前記吐出酸素に対して透過性を有し、
1よりも大きい吐出二酸化炭素対吐出分子麻酔薬選択性を前記膜が有するように、前記膜が前記吐出二酸化炭素に対して透過性を有し、
前記吐出流体混合物が前記膜と接触して、前記吐出流体混合物よりも前記吐出二酸化炭素の量が少ない改質流体混合物を前記流路内に残し、
前記流出出口は、前記膜よりも下流側に位置するとともに、少なくとも前記改質流体混合物を前記患者に提供する、
前記流入入口と;
外部流体を、前記患者へ供給される前記改質流体混合物に加えるために前記流路内へ導入するための流体入口と;
を備える、麻酔回路。 - 前記膜が少なくとも2の吐出酸素対吐出分子麻酔薬選択性を有する請求項1に記載の麻酔回路。
- 前記膜が少なくとも2の吐出二酸化炭素対吐出分子麻酔薬選択性を有する請求項1または2に記載の麻酔回路。
- 前記膜が全体的に高分子材料からなる請求項1から3のいずれか一項に記載の麻酔回路。
- 前記膜は、前記流路の外部に位置する二次酸素が前記膜を通過して前記流路に入るように構成される請求項1から4のいずれか一項に記載の麻酔回路。
- 前記外部流体を外部酸素で富化させるための外部酸素源を更に備える請求項1から5のいずれか一項に記載の麻酔回路。
- 前記流路を通じた前記吐出流体混合物および前記改質流体混合物の流れを促進させるための少なくとも1つの流れ発生器を更に備える請求項1から6のいずれか一項に記載の麻酔回路。
- 前記吐出流体混合物と前記膜との間の接触を増やすように前記吐出流体混合物の乱流を前記膜において形成するための乱流誘発構成要素を前記流路内に更に備える請求項1から7のいずれか一項に記載の麻酔回路。
- 前記吐出分子麻酔薬が揮発性麻酔薬であり、前記膜が、前記揮発性麻酔薬に対して少なくとも部分的に不透過性である請求項1から8のいずれか一項に記載の麻酔回路。
- 前記吐出分子麻酔薬がポリハロゲン化エーテルを含む請求項1から9のいずれか一項に記載の麻酔回路。
- 前記吐出分子麻酔薬は、セボフルラン、イソフルラン、またはデスフルランのうちの少なくとも1つを含む請求項1から10のいずれか一項に記載の麻酔回路。
- 前記吐出分子麻酔薬が168g/モルよりも大きい分子量を有する請求項1から11のいずれか一項に記載の麻酔回路。
- 二酸化炭素吸収材料が前記膜の、前記流路の外部にある側に位置し、前記膜は、前記二酸化炭素吸収材料を前記流路内に保持される前記吐出分子麻酔薬から分離して、前記吐出分子麻酔薬が前記二酸化炭素吸収材料と接触するのを妨げる請求項1から12のいずれか一項に記載の麻酔回路。
- 前記二酸化炭素吸収材料は、ソーダ石灰、アルカノ石灰、アルカノールアミン、アミノ化合物、アミノ酸のアルカリ塩、グリシン、DL−アラニン、β−アラニン、セリン、トレオニン、イソロイシン、DL−バリン、ピペラジン−2−カルボキシ酸、プロリン、アルギニン、γ−アミノ酪酸、オルニチン、グリシン酸カリウム、トレオン酸カリウム、タウリン、クレアチン、およびヒスチジンのうちの少なくとも1つを含む請求項13に記載の麻酔回路。
- 前記吐出流体混合物は、アセトアルデヒド、アセトン、エタン、エチレン、水素、イソプレン、メタン、メチルアミン、またはペンタンを含む代謝物質を含み、
前記膜が前記代謝物質に対して透過性を有し、
前記吐出流体混合物は前記膜と接触して、前記吐出流体混合物よりも前記代謝物質の量が少ない改質流体混合物を前記流路内に残す、請求項1から14のいずれか一項に記載の麻酔回路。 - 前記膜がポリハロカーボン膜である請求項1から15のいずれか一項に記載の麻酔回路。
- 前記膜がポリメチルペンテン膜である請求項1から16のいずれか一項に記載の麻酔回路。
- 前記膜がポリシロキサン膜である請求項1から15のいずれか一項に記載の麻酔回路。
- 前記膜がポリジメチルシロキサン膜である請求項1から15および18のいずれか一項に記載の麻酔回路。
- 前記膜が高密度膜である請求項1から19のいずれか一項に記載の麻酔回路。
- 前記膜は、多孔質支持層および高密度層を備える少なくとも1つの壁を有する中空繊維を備える非対称膜である請求項20に記載の麻酔回路。
- 前記膜は、ガラス質高分子、高分子サイズ選択膜、または、複合高分子膜を備える請求項1から21のいずれか一項に記載の麻酔回路。
- 前記膜は、前記吐出二酸化炭素に対して完全に不活性であり、アミノ酸を全く有しない請求項1から22のいずれか一項に記載の麻酔回路。
- 患者の麻酔処置のための方法であって、
分子麻酔薬を含む外部麻酔薬を、流路を介して前記患者へ向けて前記患者内に導入するステップと、
吐出酸素、吐出二酸化炭素、および吐出分子麻酔薬を含む吐出流体混合物を前記患者から離れるように前記患者から外へと前記流路内へ方向付けるステップと、
前記吐出流体混合物を前記流路を通じて、高分子材料を含み前記流路と流体連通する膜へ向けて押し進めて前記膜と接触させるステップと、
前記吐出流体混合物が前記膜と接触して改質流体混合物を前記流路内に残した後に、前記吐出分子麻酔薬よりも多い前記吐出二酸化炭素を前記吐出流体混合物から前記膜を通じて前記流路の外へ移送するステップであって、前記改質流体混合物は、前記吐出流体混合物よりも低い濃度の前記吐出二酸化炭素を有する、ステップと、
改質流体混合物を前記流路内に残すように、前記吐出流体混合物が前記膜と接触した後に、吐出酸素を、前記膜を通じて移送するステップであって、1よりも大きい吐出酸素対吐出分子麻酔薬選択性を前記膜が有する、ステップと、
前記改質流体混合物を、前記流路を通じて前記患者へと押し進めて、少なくとも前記改質流体混合物を前記患者に供給するステップと、
を含む方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161499038P | 2011-06-20 | 2011-06-20 | |
US61/499,038 | 2011-06-20 | ||
PCT/CA2012/000605 WO2012174649A1 (en) | 2011-06-20 | 2012-06-20 | An anesthetic circuit and a method for using the anesthetic circuit |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2014519928A true JP2014519928A (ja) | 2014-08-21 |
JP6215199B2 JP6215199B2 (ja) | 2017-10-18 |
Family
ID=47421944
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014516143A Active JP6215199B2 (ja) | 2011-06-20 | 2012-06-20 | 麻酔回路およびこの麻酔回路を使用するための方法 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20130068222A1 (ja) |
EP (1) | EP2720744B1 (ja) |
JP (1) | JP6215199B2 (ja) |
CA (1) | CA2839670C (ja) |
WO (1) | WO2012174649A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2016500306A (ja) * | 2012-12-22 | 2016-01-12 | ディエムエフ・メディカル・インコーポレーテッド | 中空糸膜を有する麻酔回路 |
JP2019514671A (ja) * | 2016-04-21 | 2019-06-06 | スリーエム イノベイティブ プロパティズ カンパニー | 麻酔回路に用いる中空糸膜 |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102011052187A1 (de) * | 2011-07-27 | 2013-01-31 | Maquet Vertrieb Und Service Deutschland Gmbh | Anordnung zum Entfernen von Kohlenstoffdioxid aus einem exkorporalen Blutstrom mittels Inertgasen |
CN109091737A (zh) * | 2018-09-21 | 2018-12-28 | 于兆祥 | 一种手术用麻醉呼吸装置 |
CN111888946B (zh) * | 2020-08-17 | 2022-08-30 | 杭州科百特科技有限公司 | 一种用于血液氧合的非对称疏水性聚烯烃中空纤维膜及其制备方法与用途 |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999010034A1 (en) * | 1997-08-21 | 1999-03-04 | Instrumentarium Corp. | Device and method for determining gas volume and volumetric changes in an anaesthesia system |
JP2000005314A (ja) * | 1998-06-23 | 2000-01-11 | Taiyo Toyo Sanso Co Ltd | 加湿管 |
JP2001252358A (ja) * | 2000-03-10 | 2001-09-18 | Nippon Sanso Corp | キセノンを使用した麻酔方法及び装置 |
EP1424092A1 (en) * | 2002-11-28 | 2004-06-02 | Maquet Critical Care AB | Carbon dioxide absorber |
JP2005512615A (ja) * | 2001-10-17 | 2005-05-12 | ミンラッド インコーポレイテッド | 意識の鎮静のための薬物送達システム |
JP2005515061A (ja) * | 2002-01-24 | 2005-05-26 | メムブラーナ ゲゼルシャフト ミット ベシュレンクテル ハフツング | インテグラル非対称構造を有するポリオレフィン膜及びその製造法 |
JP2006087683A (ja) * | 2004-09-24 | 2006-04-06 | Teijin Pharma Ltd | 酸素濃縮装置 |
JP2006224076A (ja) * | 2005-02-14 | 2006-08-31 | Fukuhara Co Ltd | 酸素富化ガスの製造装置。 |
US20070017516A1 (en) * | 2005-07-14 | 2007-01-25 | Klaus Schmidt | Device and process for providing gas mixtures |
WO2008142665A1 (en) * | 2007-05-23 | 2008-11-27 | L'air Liquide Societe Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude | Xenon recovery from ambient pressure ventilator loop |
US20100258117A1 (en) * | 2007-09-10 | 2010-10-14 | Stefan Hargasser | Anaesthesia Breathing System |
US20110041848A1 (en) * | 2007-10-29 | 2011-02-24 | Poseidon Diving Systems | Oxygen control in breathing apparatus |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2966235A (en) * | 1958-09-24 | 1960-12-27 | Selas Corp Of America | Separation of gases by diffusion through silicone rubber |
BE633038A (ja) * | 1961-02-27 | |||
US3489144A (en) * | 1967-02-13 | 1970-01-13 | Gen Electric | Closed rebreather - respirator circuit for renovation and supply of oxygen/nitrogen gas mixture |
US5032245A (en) * | 1990-01-04 | 1991-07-16 | Eltech Systems Corporation | Reticulate electrode bus connection |
US5355872B1 (en) * | 1992-03-04 | 1998-10-20 | John H Riggs | Low flow rate nebulizer apparatus and method of nebulization |
US5925831A (en) * | 1997-10-18 | 1999-07-20 | Cardiopulmonary Technologies, Inc. | Respiratory air flow sensor |
IT1312320B1 (it) * | 1999-05-25 | 2002-04-15 | Ausimont Spa | Membrane di polimeri amorfi (per) fluorurati. |
JP4599656B2 (ja) * | 2000-04-26 | 2010-12-15 | 宇部興産株式会社 | 中空糸分離膜エレメント、中空糸分離膜モジュール、および、その製造方法 |
US6856327B2 (en) * | 2002-07-31 | 2005-02-15 | Domotion Ltd. | Apparatus for moving display screen of mobile computer device |
GB0228074D0 (en) * | 2002-12-02 | 2003-01-08 | Molecular Products Ltd | Carbon dioxide absorption |
CA2519456A1 (en) * | 2003-03-17 | 2004-09-30 | Michael G. Goggins | Aberrantly methylated genes in pancreatic cancer |
US20070292945A1 (en) * | 2004-03-25 | 2007-12-20 | Lin Wenglong R | Cell Culture Apparatus and Methods |
US7169213B2 (en) * | 2004-10-29 | 2007-01-30 | Corning Incorporated | Multi-channel cross-flow porous device |
WO2006058301A2 (en) * | 2004-11-29 | 2006-06-01 | Avery Dennison Corporation | Coextruded multilayer colored films |
US20070001751A1 (en) * | 2005-07-01 | 2007-01-04 | Ess Technology, Inc. | System and method for providing an accurate reference bias current |
US7832398B2 (en) * | 2005-12-29 | 2010-11-16 | General Elecrtic Company | Arrangement in connection with an anaesthesia/ventilation system for a patient and a gas separation unit for an anaesthesia/ventilation system |
FR2900842B1 (fr) * | 2006-05-10 | 2009-01-23 | Inst Francais Du Petrole | Procede de desacidification d'un effluent gazeux avec extraction des produits a regenerer |
DE102006034601B3 (de) | 2006-07-26 | 2008-02-07 | Schmidt, Klaus, Prof. Dr. | Rückhaltung von Edelgasen im Atemgas bei beatmeten Patienten mit Hilfe von Membranseparation |
US20080077035A1 (en) * | 2006-09-25 | 2008-03-27 | Baker Clark R | Carbon dioxide-sensing airway products and technique for using the same |
US20090145761A1 (en) * | 2007-12-11 | 2009-06-11 | Van Hassel Bart A | Oxygen separation element and method |
CN102006903A (zh) * | 2008-01-22 | 2011-04-06 | 维波真尼克斯公司 | 挥发性麻醉组合物和应用方法 |
-
2012
- 2012-06-20 WO PCT/CA2012/000605 patent/WO2012174649A1/en active Application Filing
- 2012-06-20 US US13/528,090 patent/US20130068222A1/en not_active Abandoned
- 2012-06-20 JP JP2014516143A patent/JP6215199B2/ja active Active
- 2012-06-20 CA CA2839670A patent/CA2839670C/en active Active
- 2012-06-20 EP EP12803346.1A patent/EP2720744B1/en active Active
Patent Citations (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001504745A (ja) * | 1997-08-21 | 2001-04-10 | インストルメンタリウム コーポレイション | 麻酔システムにおけるガス体積および体積変化を測定するための装置および方法 |
WO1999010034A1 (en) * | 1997-08-21 | 1999-03-04 | Instrumentarium Corp. | Device and method for determining gas volume and volumetric changes in an anaesthesia system |
JP2000005314A (ja) * | 1998-06-23 | 2000-01-11 | Taiyo Toyo Sanso Co Ltd | 加湿管 |
JP2001252358A (ja) * | 2000-03-10 | 2001-09-18 | Nippon Sanso Corp | キセノンを使用した麻酔方法及び装置 |
JP2005512615A (ja) * | 2001-10-17 | 2005-05-12 | ミンラッド インコーポレイテッド | 意識の鎮静のための薬物送達システム |
JP2005515061A (ja) * | 2002-01-24 | 2005-05-26 | メムブラーナ ゲゼルシャフト ミット ベシュレンクテル ハフツング | インテグラル非対称構造を有するポリオレフィン膜及びその製造法 |
US20050145107A1 (en) * | 2002-01-24 | 2005-07-07 | Erich Kessler | Polyolefin membrane with integrally asymmetrical tructure and process for producing such a membrane |
EP1424092A1 (en) * | 2002-11-28 | 2004-06-02 | Maquet Critical Care AB | Carbon dioxide absorber |
JP2004174258A (ja) * | 2002-11-28 | 2004-06-24 | Maquet Critical Care Ab | 麻酔システムで使用するためのチューブ |
JP2006087683A (ja) * | 2004-09-24 | 2006-04-06 | Teijin Pharma Ltd | 酸素濃縮装置 |
JP2006224076A (ja) * | 2005-02-14 | 2006-08-31 | Fukuhara Co Ltd | 酸素富化ガスの製造装置。 |
US20070017516A1 (en) * | 2005-07-14 | 2007-01-25 | Klaus Schmidt | Device and process for providing gas mixtures |
JP2009501031A (ja) * | 2005-07-14 | 2009-01-15 | クラウス シュミット | ガス混合物を提供する装置及び方法 |
WO2008142665A1 (en) * | 2007-05-23 | 2008-11-27 | L'air Liquide Societe Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude | Xenon recovery from ambient pressure ventilator loop |
US20100258117A1 (en) * | 2007-09-10 | 2010-10-14 | Stefan Hargasser | Anaesthesia Breathing System |
JP2010538688A (ja) * | 2007-09-10 | 2010-12-16 | シュテファン・ハルガッサー | 麻酔用呼吸システム |
US20110041848A1 (en) * | 2007-10-29 | 2011-02-24 | Poseidon Diving Systems | Oxygen control in breathing apparatus |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2016500306A (ja) * | 2012-12-22 | 2016-01-12 | ディエムエフ・メディカル・インコーポレーテッド | 中空糸膜を有する麻酔回路 |
US10076620B2 (en) | 2012-12-22 | 2018-09-18 | Dmf Medical Incorporated | Anesthetic circuit having a hollow fiber membrane |
US10960160B2 (en) | 2012-12-22 | 2021-03-30 | Dmf Medical Incorporated | Anesthetic circuit having a hollow fiber membrane |
JP2019514671A (ja) * | 2016-04-21 | 2019-06-06 | スリーエム イノベイティブ プロパティズ カンパニー | 麻酔回路に用いる中空糸膜 |
JP7105197B2 (ja) | 2016-04-21 | 2022-07-22 | スリーエム イノベイティブ プロパティズ カンパニー | 麻酔回路に用いる中空糸膜 |
Also Published As
Publication number | Publication date |
---|---|
WO2012174649A1 (en) | 2012-12-27 |
EP2720744A1 (en) | 2014-04-23 |
US20130068222A1 (en) | 2013-03-21 |
CA2839670A1 (en) | 2012-12-27 |
EP2720744B1 (en) | 2017-09-06 |
EP2720744A4 (en) | 2015-03-04 |
CA2839670C (en) | 2016-05-24 |
JP6215199B2 (ja) | 2017-10-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10960160B2 (en) | Anesthetic circuit having a hollow fiber membrane | |
JP6215199B2 (ja) | 麻酔回路およびこの麻酔回路を使用するための方法 | |
JP5977786B2 (ja) | 一酸化窒素発生システム | |
JP5901684B2 (ja) | 一酸化窒素発生のためのシステム及び装置 | |
EP1803479A1 (en) | Gas separation unit for an anaesthesia/ventilation system | |
US20210170328A1 (en) | Hollow Fiber Membrane For Use in an Anesthetic Circuit | |
WO2017100730A1 (en) | Method and apparatus for scavenging plasma free hemoglobin | |
JP2011514833A (ja) | ベンチレータからキセノンの回収および再利用のためのシステムおよび方法 | |
US20100258117A1 (en) | Anaesthesia Breathing System | |
US7625427B2 (en) | Apparatus and process for carbon dioxide absorption | |
US10596344B2 (en) | Anesthesia device and method of controlling hydrogen concentration in a hydrogen-containing anesthesia gas | |
EP2344219A1 (en) | Xenon-based gaseous anaesthetic to be administered via a heart lung machine | |
US20220040393A1 (en) | Device and Method for Attenuation of CO2 in Circulating Blood | |
Ramajeyam et al. | Low Flow Anaesthesia Technique |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20150612 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20160309 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20160318 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160615 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20161205 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170301 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20170821 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20170920 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6215199 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |